• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Intensive induction chemotherapy vs hypomethylating agent-based regimen in patients aged ≥70 years with newly diagnosed acute myeloid leukemia.

作者信息

Lim Matthew J, Agha Aya, Im Annie, Raptis Anastasios, Hou Jing Z, Boyiadzis Michael, Sehgal Alison R, Redner Robert L, Dorritie Kathleen, Marks Stanley S, Agha Mounzer E, Lim Seah H

机构信息

Mario Lemieux Center for Blood Cancers, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

出版信息

Hematol Oncol. 2018 Apr;36(2):495-497. doi: 10.1002/hon.2456. Epub 2017 Jun 30.

DOI:10.1002/hon.2456
PMID:28664979
Abstract
摘要

相似文献

1
Intensive induction chemotherapy vs hypomethylating agent-based regimen in patients aged ≥70 years with newly diagnosed acute myeloid leukemia.≥70岁新诊断急性髓系白血病患者强化诱导化疗与基于去甲基化药物方案的对比
Hematol Oncol. 2018 Apr;36(2):495-497. doi: 10.1002/hon.2456. Epub 2017 Jun 30.
2
Therapeutic decision-making in elderly patients with acute myeloid leukemia: conventional intensive chemotherapy versus hypomethylating agent therapy.老年急性髓系白血病患者的治疗决策：传统强化化疗与去甲基化药物治疗对比
Ann Hematol. 2017 Nov;96(11):1801-1809. doi: 10.1007/s00277-017-3104-9. Epub 2017 Aug 21.
3
Comparison of induction strategies and responses for acute myeloid leukemia patients after resistance to hypomethylating agents for antecedent myeloid malignancy.比较先前存在的髓系恶性肿瘤患者对低甲基化药物耐药后急性髓系白血病患者的诱导策略和反应。
Leuk Res. 2020 Jun;93:106367. doi: 10.1016/j.leukres.2020.106367. Epub 2020 May 1.
4
Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the Study Alliance Leukemia.阿扎胞苷联合强化诱导化疗治疗老年急性髓系白血病：白血病研究联盟 AML-AZA 试验。
Leukemia. 2016 Mar;30(3):555-61. doi: 10.1038/leu.2015.306. Epub 2015 Nov 2.
5
Real-world data on treatment patterns and outcomes of hypomethylating therapy in patients with newly diagnosed acute myeloid leukaemia aged ≥ 60 years.≥60岁新诊断急性髓系白血病患者甲基化治疗模式及疗效的真实世界数据。
Br J Haematol. 2020 Apr;189(1):e13-e16. doi: 10.1111/bjh.16410. Epub 2020 Feb 26.
6
Outcomes in obese and overweight acute myeloid leukemia patients receiving chemotherapy dosed according to actual body weight.根据实际体重给肥胖和超重的急性髓系白血病患者化疗的结果。
Am J Hematol. 2013 Oct;88(10):906-9. doi: 10.1002/ajh.23530. Epub 2013 Aug 30.
7
Venetoclax and hypomethylating agent combination therapy in acute myeloid leukemia secondary to a myeloproliferative neoplasm.维奈托克与低甲基化药物联合治疗骨髓增殖性肿瘤继发的急性髓系白血病
Leuk Res. 2020 Nov;98:106456. doi: 10.1016/j.leukres.2020.106456. Epub 2020 Sep 22.
8
CLAG-based induction therapy in previously untreated high risk acute myeloid leukemia patients.基于CLAG的诱导疗法用于既往未治疗的高危急性髓系白血病患者。
Leuk Res. 2016 Jul;46:74-8. doi: 10.1016/j.leukres.2016.04.015. Epub 2016 Apr 26.
9
Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients.老年急性髓系白血病患者的强化化疗及减低强度异基因造血干细胞移植
Asia Pac J Clin Oncol. 2014 Sep;10(3):246-54. doi: 10.1111/ajco.12188. Epub 2014 Mar 27.
10
All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study.全反式维甲酸作为年轻成年急性髓系白血病患者强化治疗的辅助用药：随机化AMLSG 07-04研究结果
Ann Hematol. 2016 Dec;95(12):1931-1942. doi: 10.1007/s00277-016-2810-z. Epub 2016 Oct 3.